CHL [CHINA MOBILE] 6-K: (Original Filing)
[Number Page 1.1 Announcement, dated August 10, 2015 A-1 -2- CHINA MOBILE LIMITED]
JD [JD.com] 6-K: (Original Filing)
[Exhibi 99.1 JD.com Announces Second Quarter 2015 Results Beijing, China Second Quarter 2015 Highlights 1 · Net revenues services and others · Net loss Non-GAAP net loss 2 non-GAAP net margin · GMV · Annual active customer accounts 3 · Fulfilled orders 1 The U.S. dollar (USD) amounts disclosed in this press release, except for those transaction amounts that] [001-36450 JD.com, Inc. 10th Floor, Building A, North Star Century Center Form 20-F x o o o JD.COM, INC. By : :]
CHL [CHINA MOBILE] 6-K: Number Page 1.1 Announcement, dated August 10, 2015
[Number Page 1.1 Announcement, dated August 10, 2015 A-1 -2- CHINA MOBILE LIMITED]
JD [JD.com] 6-K: Exhibi 99.1 JD.com Announces Second Quarter 2015 Results
[Exhibi 99.1 JD.com Announces Second Quarter 2015 Results Beijing, China Second Quarter 2015 Highlights 1 · Net revenues services and others · Net loss Non-GAAP net loss 2 non-GAAP net margin · GMV · Annual active customer accounts 3 · Fulfilled orders 1 The U.S. dollar (USD) amounts disclosed in this press release, except for those transaction amounts that] [001-36450 JD.com, Inc. 10th Floor, Building A, North Star Century Center Form 20-F x o o o JD.COM, INC. By : :]
TPI [TIANYIN PHARMACEUTICAL] 8-K: (Original Filing)
[8-K 1 f8k080615_tianyinpharma.htm CURRENT REPORT]
TPI [TIANYIN PHARMACEUTICAL] 8-K: 8-K 1 f8k080615_tianyinpharma.htm CURRENT REPORT
[8-K 1 f8k080615_tianyinpharma.htm CURRENT REPORT]
TPI [TIANYIN PHARMACEUTICAL] 10-Q: (Original Filing)
[] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended March 31, 2015 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, Guoqing Jiang, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended March 31, 2015 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Chief Executive Officer, Chief Accounting Officer, Chairman EX-32.1 4 f10q0315ex32i_tianyinpharma.htm CERTIFICATION] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Acting Chief Financial Officer EX-32.2 5 f10q0315ex32ii_tianyinpharma.htm CERTIFICATION]
TPI [TIANYIN PHARMACEUTICAL] 10-Q:
[] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended March 31, 2015 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, Guoqing Jiang, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended March 31, 2015 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Chief Executive Officer, Chief Accounting Officer, Chairman EX-32.1 4 f10q0315ex32i_tianyinpharma.htm CERTIFICATION] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Acting Chief Financial Officer EX-32.2 5 f10q0315ex32ii_tianyinpharma.htm CERTIFICATION]
